Skip to main content
Erschienen in: Virchows Archiv 2/2006

01.02.2006 | Case Report

Follicular dendritic cell tumor of the mediastinum: expression of fractalkine and SDF-1α as mast cell chemoattractants

verfasst von: Catherine Guettier, Pierre Validire, Dominique Emilie, Viviane Tricottet, Mylène Sebagh, Aurora Anjo, Jean-Louis Misset, Michel Reynes

Erschienen in: Virchows Archiv | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Follicular dendritic cell tumor (FDCT) is a rare tumor mainly located in laterocervical lymph nodes. We report one case of mediastinal FDCT associated with a history of bullous skin disease and clinically obvious immunosuppression. This tumor was characterized by heavy mast cell infiltration. Mast cells were in close relationship with tumor cells as demonstrated by ultrastructural examination and their presence are probably related with the strong expression of mast cell chemoattractants as fraktalkine and stromal cell-derived factor-1α by tumor cells. The long follow-up period of more than 17 years allowed to us assess the relatively indolent evolution of this tumor characterized by three slowly growing local recurrences without metastasis.
Literatur
1.
Zurück zum Zitat Chan JK, Fletcher CD, Nayler SJ, Cooper K (1997) Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 79:294–313CrossRefPubMed Chan JK, Fletcher CD, Nayler SJ, Cooper K (1997) Follicular dendritic cell sarcoma. Clinicopathologic analysis of 17 cases suggesting a malignant potential higher than currently recognized. Cancer 79:294–313CrossRefPubMed
2.
Zurück zum Zitat Coulomb-L’Herminé A, Amara A, Schiff C, Durand-Gasselin I, Foussat A, Delaunay T, Chaouat G, Capron F, Ledee N, Galanaud P, Arenzana-Seisdedos F, Emilie D (1999) Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc Natl Acad Sci U S A 96:8585–8590CrossRef Coulomb-L’Herminé A, Amara A, Schiff C, Durand-Gasselin I, Foussat A, Delaunay T, Chaouat G, Capron F, Ledee N, Galanaud P, Arenzana-Seisdedos F, Emilie D (1999) Stromal cell-derived factor 1 (SDF-1) and antenatal human B cell lymphopoiesis: expression of SDF-1 by mesothelial cells and biliary ductal plate epithelial cells. Proc Natl Acad Sci U S A 96:8585–8590CrossRef
3.
Zurück zum Zitat Desai SB, Pradhan SA, Chinoy RF (2000) Mediastinal Castleman’s disease complicated by follicular dendritic cell tumour. Indian J Cancer 37:129–132PubMed Desai SB, Pradhan SA, Chinoy RF (2000) Mediastinal Castleman’s disease complicated by follicular dendritic cell tumour. Indian J Cancer 37:129–132PubMed
4.
Zurück zum Zitat Fassina A, Marino F, Poletti A, Rea F, Pennelli N, Ninfo V (2001) Follicular dendritic cell tumor of the mediastinum. Ann Diagn Pathol 5:361–367CrossRefPubMed Fassina A, Marino F, Poletti A, Rea F, Pennelli N, Ninfo V (2001) Follicular dendritic cell tumor of the mediastinum. Ann Diagn Pathol 5:361–367CrossRefPubMed
5.
Zurück zum Zitat Foussat A, Coulomb-L’Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30:87–97CrossRefPubMed Foussat A, Coulomb-L’Hermine A, Gosling J, Krzysiek R, Durand-Gasselin I, Schall T, Balian A, Richard Y, Galanaud P, Emilie D (2000) Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur J Immunol 30:87–97CrossRefPubMed
6.
Zurück zum Zitat Grogg KL, Lae ME, Kurtin PJ, Macon WR (2004) Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 28:988–998PubMedCrossRef Grogg KL, Lae ME, Kurtin PJ, Macon WR (2004) Clusterin expression distinguishes follicular dendritic cell tumors from other dendritic cell neoplasms: report of a novel follicular dendritic cell marker and clinicopathologic data on 12 additional follicular dendritic cell tumors and 6 additional interdigitating dendritic cell tumors. Am J Surg Pathol 28:988–998PubMedCrossRef
7.
Zurück zum Zitat Husson H, Carideo EG, Cardoso AA, Lugli SM, Neuberg D, Munoz O, de Leval L, Schultze J, Freedman AS (2001) MCP-1 modulates chemotaxis by follicular lymphoma cells. Br J Haematol 115:554–562CrossRefPubMed Husson H, Carideo EG, Cardoso AA, Lugli SM, Neuberg D, Munoz O, de Leval L, Schultze J, Freedman AS (2001) MCP-1 modulates chemotaxis by follicular lymphoma cells. Br J Haematol 115:554–562CrossRefPubMed
8.
Zurück zum Zitat Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G (2000) The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 30:3614–3622CrossRefPubMed Juremalm M, Hjertson M, Olsson N, Harvima I, Nilsson K, Nilsson G (2000) The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur J Immunol 30:3614–3622CrossRefPubMed
9.
Zurück zum Zitat Krober SM, Marx A, Aebert H, Dohmen BM, Kaiserling E (2004) Sarcoma of follicular dendritic cells in the dorsal mediastinum. Hum Pathol 35:259–263CrossRefPubMed Krober SM, Marx A, Aebert H, Dohmen BM, Kaiserling E (2004) Sarcoma of follicular dendritic cells in the dorsal mediastinum. Hum Pathol 35:259–263CrossRefPubMed
10.
Zurück zum Zitat Lin O, Frizzera G (1997) Angiomyoid and follicular dendritic cell proliferative lesions in Castleman’s disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol 21:1295–1306CrossRefPubMed Lin O, Frizzera G (1997) Angiomyoid and follicular dendritic cell proliferative lesions in Castleman’s disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol 21:1295–1306CrossRefPubMed
11.
Zurück zum Zitat Papadopoulos EJ, Fitzhugh DJ, Tkaczyk C, Gilfillan AM, Sassetti C, Metcalfe DD, Hwang ST (2000) Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol 30:2355–2361CrossRefPubMed Papadopoulos EJ, Fitzhugh DJ, Tkaczyk C, Gilfillan AM, Sassetti C, Metcalfe DD, Hwang ST (2000) Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin. Eur J Immunol 30:2355–2361CrossRefPubMed
12.
Zurück zum Zitat Papadopoulos EJ, Sassetti C, Saeki H, Yamada N, Kawamura T, Fitzhugh DJ, Saraf MA, Schall T, Blauvelt A, Rosen SD, Hwang ST (1999) Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol 29:2551–2559CrossRefPubMed Papadopoulos EJ, Sassetti C, Saeki H, Yamada N, Kawamura T, Fitzhugh DJ, Saraf MA, Schall T, Blauvelt A, Rosen SD, Hwang ST (1999) Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol 29:2551–2559CrossRefPubMed
13.
Zurück zum Zitat Perez-Ordonez B, Erlandson RA, Rosai J (1996) Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 20:944–955CrossRefPubMed Perez-Ordonez B, Erlandson RA, Rosai J (1996) Follicular dendritic cell tumor: report of 13 additional cases of a distinctive entity. Am J Surg Pathol 20:944–955CrossRefPubMed
14.
Zurück zum Zitat Perez-Ordonez B, Rosai J (1998) Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol 15:144–154PubMed Perez-Ordonez B, Rosai J (1998) Follicular dendritic cell tumor: review of the entity. Semin Diagn Pathol 15:144–154PubMed
15.
Zurück zum Zitat Sakurai S, Hasegawa T, Sakuma Y, Takazawa Y, Motegi A, Nakajima T, Saito K, Fukayama M, Shimoda T (2004) Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol 35:1223–1230CrossRefPubMed Sakurai S, Hasegawa T, Sakuma Y, Takazawa Y, Motegi A, Nakajima T, Saito K, Fukayama M, Shimoda T (2004) Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: a subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene. Hum Pathol 35:1223–1230CrossRefPubMed
16.
Zurück zum Zitat Seishima M, Oda M, Oyama Z, Yoshimura T, Yamazaki F, Aoki T, Nei M, Hashimoto T (2004) Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 140:1500–1503CrossRefPubMed Seishima M, Oda M, Oyama Z, Yoshimura T, Yamazaki F, Aoki T, Nei M, Hashimoto T (2004) Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma. Arch Dermatol 140:1500–1503CrossRefPubMed
17.
Zurück zum Zitat Sun X, Chang K-C, Abruzzo LV, Lai R, Younes A, Jones D (2003) Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman’s disease. Hum Pathol 34:835–840CrossRefPubMed Sun X, Chang K-C, Abruzzo LV, Lai R, Younes A, Jones D (2003) Epidermal growth factor receptor expression in follicular dendritic cells: a shared feature of follicular dendritic cell sarcoma and Castleman’s disease. Hum Pathol 34:835–840CrossRefPubMed
18.
Zurück zum Zitat Tomita Y, Aozasa K, Myoui A, Kuratsu S, Uchida A, Ono K, Matsumoto K (1993) Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer 54:194–199PubMedCrossRef Tomita Y, Aozasa K, Myoui A, Kuratsu S, Uchida A, Ono K, Matsumoto K (1993) Histologic grading in soft-tissue sarcomas. An analysis of 194 cases including AgNOR count and mast-cell count. Int J Cancer 54:194–199PubMedCrossRef
19.
Zurück zum Zitat Yavuz E, Gulluoglu MG, Akbas N, Tuzlali S, Ilhan R, Iplikci A, Akhan SE (2001) The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms. Pathol Int 51:938–941CrossRefPubMed Yavuz E, Gulluoglu MG, Akbas N, Tuzlali S, Ilhan R, Iplikci A, Akhan SE (2001) The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms. Pathol Int 51:938–941CrossRefPubMed
Metadaten
Titel
Follicular dendritic cell tumor of the mediastinum: expression of fractalkine and SDF-1α as mast cell chemoattractants
verfasst von
Catherine Guettier
Pierre Validire
Dominique Emilie
Viviane Tricottet
Mylène Sebagh
Aurora Anjo
Jean-Louis Misset
Michel Reynes
Publikationsdatum
01.02.2006
Verlag
Springer-Verlag
Erschienen in
Virchows Archiv / Ausgabe 2/2006
Print ISSN: 0945-6317
Elektronische ISSN: 1432-2307
DOI
https://doi.org/10.1007/s00428-005-0143-8

Weitere Artikel der Ausgabe 2/2006

Virchows Archiv 2/2006 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …